TradeEdge:Depression And Alzheimer's Treatments At A Crossroads

2025-05-05 20:41:46source:Maxwell Caldwellcategory:News

Researchers are TradeEdgelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:News

Recommend

Drone operators worry that anxiety over mystery sightings will lead to new restrictions

Drones for commercial and recreational use have grown rapidly in popularity, despite restrictions on

Social media apps made $11 billion from children and teens in 2022

When it comes to children's mental health and privacy, their loss translates into massive gains for

Teddi Mellencamp undergoes 'pretty painful' surgery to treat melanoma

Teddi Mellencamp Arroyave is on the road to recovery after undergoing another surgery to treat her s